IN2014DN09314A - - Google Patents

Info

Publication number
IN2014DN09314A
IN2014DN09314A IN9314DEN2014A IN2014DN09314A IN 2014DN09314 A IN2014DN09314 A IN 2014DN09314A IN 9314DEN2014 A IN9314DEN2014 A IN 9314DEN2014A IN 2014DN09314 A IN2014DN09314 A IN 2014DN09314A
Authority
IN
India
Prior art keywords
processes
formula
pfiol
aria
quinolone
Prior art date
Application number
Inventor
Ian Hugh Gilbert
Neil Norcross
Ruibal Beatriz Baragana
Achim Porzelle
Original Assignee
Univ Dundee
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Dundee filed Critical Univ Dundee
Publication of IN2014DN09314A publication Critical patent/IN2014DN09314A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/50—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4
    • C07D215/52—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4 with aryl radicals attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/541—Non-condensed thiazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)

Abstract

The present invention relates to a novel class of quinolone-4-carboxamide PfiOl inhibitors of general formula (I)(Formula (I)) wherein R1, R2, R3, R4, R5, R6, R7, R8 and X are as defined herein, to their use in medicine, and in the treatment of mal - aria in particular, to compositions containing them, to processes for their preparation and to intermediates used in such processes.
IN9314DEN2014 2012-04-10 2013-03-14 IN2014DN09314A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1206280.8A GB201206280D0 (en) 2012-04-10 2012-04-10 Anti-malarial agents
PCT/GB2013/050633 WO2013153357A1 (en) 2012-04-10 2013-03-14 Anti-malarial agents

Publications (1)

Publication Number Publication Date
IN2014DN09314A true IN2014DN09314A (en) 2015-07-10

Family

ID=46177063

Family Applications (1)

Application Number Title Priority Date Filing Date
IN9314DEN2014 IN2014DN09314A (en) 2012-04-10 2013-03-14

Country Status (16)

Country Link
US (1) US9115088B2 (en)
EP (1) EP2836483B1 (en)
JP (1) JP6088639B2 (en)
CN (1) CN104302624B (en)
BR (1) BR112014025416B1 (en)
CA (1) CA2870140C (en)
ES (1) ES2587683T3 (en)
GB (1) GB201206280D0 (en)
HU (1) HUE030572T2 (en)
IN (1) IN2014DN09314A (en)
MY (1) MY166153A (en)
PH (1) PH12014502285B1 (en)
PT (1) PT2836483T (en)
SG (1) SG11201406548WA (en)
WO (1) WO2013153357A1 (en)
ZA (1) ZA201408094B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201610724D0 (en) 2016-06-20 2016-08-03 Univ Dundee Anti-infective agents
CN108101842B (en) * 2017-12-29 2021-04-30 山东诚汇双达药业有限公司 Preparation method of 2-hydroxy-4-carboxyquinoline
MX2020009711A (en) * 2018-04-11 2020-10-07 Merck Patent Gmbh Combination of quinoline-4-carboxamides and benzonaphthyridine derivatives as antimalarial drug combination.
CN111084774B (en) * 2019-11-29 2021-06-15 中国科学院广州生物医药与健康研究院 Application of pyrrolidine compound composition in the preparation of antimalarial drugs
WO2021149692A1 (en) * 2020-01-21 2021-07-29 Eisai R&D Management Co., Ltd. Novel antimalarial agent containing heterocyclic compound
EP3892332A1 (en) * 2020-04-09 2021-10-13 University Of Kentucky Research Foundation New anti-malarial agents
EP4608514A1 (en) * 2022-10-24 2025-09-03 CeMM - Forschungszentrum für Molekulare Medizin GmbH Tasl mimicking molecules and applications thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2502264A (en) 1946-06-25 1950-03-28 Us Sec War Quinoline derivatives having antimalarial properties
JPH0873355A (en) * 1994-09-02 1996-03-19 Mitsui Toatsu Chem Inc Antimalarial drug resistance overcoming agent
TR199800854T2 (en) * 1995-11-16 1998-08-21 F.Hoffmann-La Roche Ag Antis�tma quinoline turret.
AU757059B2 (en) * 1997-06-19 2003-01-30 Sepracor, Inc. Quinoline-indole antimicrobial agents, uses and compositions related thereto
ES2421448T3 (en) * 2005-10-21 2013-09-02 Actelion Pharmaceuticals Ltd Piperazine derivatives as agents against malaria

Also Published As

Publication number Publication date
WO2013153357A1 (en) 2013-10-17
CN104302624A (en) 2015-01-21
PH12014502285A1 (en) 2014-12-15
ES2587683T3 (en) 2016-10-26
SG11201406548WA (en) 2015-01-29
BR112014025416A2 (en) 2013-10-17
HUE030572T2 (en) 2017-05-29
JP2015512930A (en) 2015-04-30
ZA201408094B (en) 2017-08-30
BR112014025416B1 (en) 2020-04-22
BR112014025416A8 (en) 2018-06-12
CN104302624B (en) 2016-01-13
CA2870140A1 (en) 2013-10-17
PH12014502285B1 (en) 2014-12-15
MY166153A (en) 2018-06-06
CA2870140C (en) 2018-06-26
EP2836483B1 (en) 2016-07-27
GB201206280D0 (en) 2012-05-23
EP2836483A1 (en) 2015-02-18
US9115088B2 (en) 2015-08-25
JP6088639B2 (en) 2017-03-01
US20150045354A1 (en) 2015-02-12
PT2836483T (en) 2016-08-26

Similar Documents

Publication Publication Date Title
PH12015501385A1 (en) Autotaxin inhibitors
PH12014502597A1 (en) N-substituted benzamides and their use in the treatment of pain
MX338114B (en) Inhibitors of arginase and their therapeutic applications.
EA201190235A1 (en) SUBSTITUTED 1-CYANOETHYLGETHERO CYCLILCARBOXAMIDE COMPOUNDS 750
EA201500652A1 (en) DIFTLOROMETILNIKOTINOVY INDANILKARBOKSAMIDY
MD20150043A2 (en) Inhibitors of histone demethylases
PH12014000179A1 (en) New pyrrole compounds, a process for their preparation and pharmaceutical compositions containing them
MX336381B (en) Boronates as arginase inhibitors.
PH12015500347A1 (en) 6-amino acid heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection
MY186599A (en) Substituted pyridopyrazines as novel syk inhibitors
PH12014501514A1 (en) New azetidine derivatives, pharmaceutical compositions and uses thereof
MX2015001099A (en) New bicyclicpyridine derivatives.
PH12015501609A1 (en) Phenicol antibacterials
GEP201706621B (en) Benzamides
TW201613864A (en) Novel compounds
PH12015501175A1 (en) Substituted pyridopyrazines as syk inhibitors
PH12014502285A1 (en) Anti-malarial agents
MY166449A (en) Pharmaceutical composition of rosuvastatin calcium
PH12015501038A1 (en) Inhibitors of iap
MX362879B (en) Novel uses.
MX2015001834A (en) New antibacterial compounds.
MX2015001835A (en) New antibacterial compounds.
MX348841B (en) Pyrimidooxazocine derivatives as mtor - inhibitors.
MX2013006670A (en) 2-carboxamide-4-piperazinyl-benzofuran derivative.
IN2015DN02109A (en)